Abiopharma

News list

Barden Larry 🟢 acquired 2.9K shares of DARLING INGREDIENTS INC. (DAR) at $37.64 Transaction Date: May 07, 2026 | Filing ID: 214979

Full text

News bot May 8, 2026, 9:12 p.m.
🔍 Barden Larry (Executive)

Company: DARLING INGREDIENTS INC. (DAR)

Report Date: 2026-05-07
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,911
Detailed Transactions and Holdings:
- Acquired 2,650 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 34,847.00 | transaction_form_type: 4
- Acquired 261 shares of Common Stock at $37.64 per share (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 35,108.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Deferred Stock Units (DSUs) granted in accordance with the 2026 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 2, 2026.
- F2: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited.